Removing HIV as a barrier to organ transplantation
Researchers at The Alfred are hoping to break down the barriers people living with HIV encounter when it comes to undergoing solid organ transplantation.
COVID-19: Find out about our screening clinic - and note our current visitor restrictions
Researchers at The Alfred are hoping to break down the barriers people living with HIV encounter when it comes to undergoing solid organ transplantation.
This year, 22-year-old Demi Lawson has not only faced a global pandemic, but a diagnosis of brain cancer, an awake craniotomy (brain surgery) – and has been learning to live with the death of her younger brother.
One of Alfred Health’s leading physician-scientists has been recognised for his ground-breaking work in the area of infectious diseases.
Associate Professor Eric Chow from the Melbourne Sexual Health Centre and Monash University was recently awarded the 2020 Commonwealth Health Minister’s Award for Excellence in Health and Medical Research.
The Alfred has banded together with a private IVF company to save a patient's chance of having children after he was diagnosed with testicular cancer.
Alfred Cancer Trials (ACT) has begun testing two new Phase 1 cancer drugs, treating the first patients in the world on these trials.
Respiratory specialists at The Alfred are urging people with asthma to review their medication after new research found one quarter of people who use inhaler controllers receive potentially toxic cumulative doses of oral corticosteroid.
Artificial intelligence (AI) could soon become a powerful tool in skin cancer assessment. The Victorian Melanoma Service is currently conducting a trial into the effectiveness of the technology.
Making up 80 per-cent of all brain tumours in adults, gliomas such as glioblastoma (GBM) are the most common and aggressive form of brain cancer. Killing more people under forty than any other cancer, a quarter of a million people die every year from these tumours – despite current treatment options the average survival for a GBM is only 14-15 months after diagnosis
Researchers from The Alfred and Monash University have set out to determine whether an antiviral medication used to treat influenza could help people with COVID-19 recover faster.